Related Experiment Video
Updated: Feb 19, 2026

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin
Wenhao Yu1, Kevin A Goncalves2, Shuping Li1
1Molecular Oncology Research Institute, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA; Department of Pathology, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
Plexin-B2 (PLXNB2) acts as the cell surface receptor for angiogenin (ANG), mediating its roles in cell growth and regeneration. Targeting this interaction shows therapeutic potential for cancers and neurodegenerative diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Medicine
Background:
- Angiogenin (ANG) is a ribonuclease (RNase) involved in cell growth, survival, and regeneration.
- ANG requires receptor-mediated endocytosis for its functions, but its cell surface receptor was previously unidentified.
Purpose of the Study:
- To identify the functional cell surface receptor for angiogenin (ANG).
- To investigate the role of this receptor in ANG-mediated cellular processes.
- To evaluate the therapeutic potential of targeting the ANG-receptor interaction.
Main Methods:
- Functional assays using various cell types (endothelial, cancer, neuronal, hematopoietic stem and progenitor cells).
- Identification of plexin-B2 (PLXNB2) as the ANG receptor.
- In vitro and in vivo studies using antibodies against the ANG-binding site on PLXNB2.
Main Results:
- Plexin-B2 (PLXNB2) was identified as the functional receptor for ANG across multiple cell types.
- PLXNB2 mediates intracellular RNA processing, contributing to ANG's effects on cell growth, survival, and regeneration.
- Antibodies targeting the PLXNB2-ANG interaction inhibited tumor growth, promoted neuroprotection, and reduced leukemia progression.
Conclusions:
- PLXNB2 is essential for both physiological and pathological functions of ANG.
- Targeting the PLXNB2-ANG interaction offers therapeutic promise for solid and hematopoietic cancers.
- The PLXNB2-ANG pathway presents a potential therapeutic target for neurodegenerative diseases.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Cytoskeletal Linker Proteins - Plakins
Intracellular Signaling Affects Focal Adhesions
Some...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

